These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 29904421)
1. Contrast-enhanced magnetic resonance imaging with a novel nano-size contrast agent for the clinical diagnosis of patients with lung cancer. Gao J; Li L; Liu X; Guo R; Zhao B Exp Ther Med; 2018 Jun; 15(6):5415-5421. PubMed ID: 29904421 [TBL] [Abstract][Full Text] [Related]
2. Ultrasonic diagnosis combined with targeted ultrasound contrast agent improves diagnostic sensitivity of ultrasonic for non-small cell lung cancer patients. Zhang X; Xiao C Exp Ther Med; 2018 Aug; 16(2):908-916. PubMed ID: 30112043 [TBL] [Abstract][Full Text] [Related]
3. Combination of magnetic resonance imaging and targeted contrast agent for the diagnosis of myocardial infarction. Qin J; Zhou S; Li Z; Chen Y; Qin Q; Ai T Exp Ther Med; 2018 Oct; 16(4):3303-3308. PubMed ID: 30233676 [TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced computed tomography combined with Chitosan-Fe Gai J; Gao Z; Song L; Xu Y; Liu W; Zhao C Exp Ther Med; 2018 Jun; 15(6):5344-5352. PubMed ID: 29805549 [TBL] [Abstract][Full Text] [Related]
5. Methylated PTGER4 is better than CA125, CEA, Cyfra211 and NSE as a therapeutic response assessment marker in stage IV lung cancer. Zhang Y; Huang J; Zou Q; Che J; Yang K; Fan Q; Qian D; Wu J; Bao E; Song L; Zhang F Oncol Lett; 2020 Apr; 19(4):3229-3238. PubMed ID: 32256818 [TBL] [Abstract][Full Text] [Related]
6. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer. Jiang ZF; Wang M; Xu JL Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745 [TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
8. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer]. Pan QR; Zhang X; Xu ZF; Zheng S Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076 [TBL] [Abstract][Full Text] [Related]
9. Serum carcinoembryonic antigen, neuron-specific enolase as biomarkers for diagnosis of nonsmall cell lung cancer. Dong Y; Zheng X; Yang Z; Sun M; Zhang G; An X; Pan L; Zhang S J Cancer Res Ther; 2016 Oct; 12(Supplement):34-36. PubMed ID: 27721249 [TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced spectral mammography (CESM) and contrast enhanced MRI (CEMRI): Patient preferences and tolerance. Hobbs MM; Taylor DB; Buzynski S; Peake RE J Med Imaging Radiat Oncol; 2015 Jun; 59(3):300-5. PubMed ID: 25900704 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of marker gene detection and computed tomography for the diagnosis of human lung cancer. Cheng M; Sun X; Liu G; Cheng K; Lv Z; Sun C; Xiu D; Liu L Oncol Lett; 2018 Oct; 16(4):4400-4406. PubMed ID: 30250539 [TBL] [Abstract][Full Text] [Related]
12. Prediction of lung cancer based on serum biomarkers by gene expression programming methods. Yu Z; Chen XZ; Cui LH; Si HZ; Lu HJ; Liu SH Asian Pac J Cancer Prev; 2014; 15(21):9367-73. PubMed ID: 25422226 [TBL] [Abstract][Full Text] [Related]
13. The diagnostic value of serum CEA, NSE and MMP-9 for on-small cell lung cancer. Xu L; Lina W; Xuejun Y Open Med (Wars); 2016; 11(1):59-62. PubMed ID: 28352768 [TBL] [Abstract][Full Text] [Related]
14. [A clinical evaluation of the versatility of various tumor markers in diagnosing the primary carcinoma of the lung]. Shimabukuro Z Nihon Ika Daigaku Zasshi; 1989 Jun; 56(3):281-93. PubMed ID: 2546967 [TBL] [Abstract][Full Text] [Related]
15. [Oblique-sagittal black-blood contrast-enhanced magnetic resonance imaging in preoperative evaluation for carotid endarterectomy]. WANG QJ; WANG Y; CAI JM; ZHAO TQ; MA L; CAI YQ; CHEN LF; WANG ZB Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):385-91. PubMed ID: 21421468 [TBL] [Abstract][Full Text] [Related]
16. An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions. Seemann MD; Beinert T; Fürst H; Fink U Lung Cancer; 1999 Dec; 26(3):149-55. PubMed ID: 10598925 [TBL] [Abstract][Full Text] [Related]
17. Application of novel targeting nanoparticles contrast agent combined with contrast-enhanced computed tomography during screening for early-phase gastric carcinoma. Zhang K; Du X; Yu K; Zhang K; Zhou Y Exp Ther Med; 2018 Jan; 15(1):47-54. PubMed ID: 29387181 [TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced ultrasound in the characterization of hepatocellular carcinomas treated by ablation: comparison with contrast-enhanced magnetic resonance imaging. Qu P; Yu X; Liang P; Cheng Z; Han Z; Liu F; Yu J Ultrasound Med Biol; 2013 Sep; 39(9):1571-9. PubMed ID: 23830098 [TBL] [Abstract][Full Text] [Related]
19. [Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)]. Kawahara M; Furuse K; Arai R; Tsuruta M; Kodama N; Hayashi S; Kiyota M; Kubota K; Mori T; Yamamoto S Gan To Kagaku Ryoho; 1987 Jan; 14(1):146-51. PubMed ID: 3026253 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer. Lee JH; Chang JH Chest; 2005 Oct; 128(4):2298-303. PubMed ID: 16236887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]